Alerts will be sent to your verified email
Verify EmailFREDUN
Fredun Pharma
|
Venus Remedies
|
Kilitch Drugs(India)
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
8.53 % | 8.87 % | 4.81 % |
5yr average Equity Multiplier
|
3.02 | 1.32 | 1.42 |
5yr Average Asset Turnover Ratio
|
1.01 | 0.96 | 0.51 |
5yr Avg Net Profit Margin
|
2.89 % | 6.91 % | 6.07 % |
Price to Book
|
4.1 | 1.02 | 3.07 |
P/E
|
24.75 | 10.69 | 22.2 |
5yr Avg Cash Conversion Cycle
|
137.13 Days | 46.96 Days | -7.56 Days |
Inventory Days
|
140.46 Days | 75.64 Days | 17.9 Days |
Days Receivable
|
52.11 Days | 54.28 Days | 138.92 Days |
Days Payable
|
131.93 Days | 58.86 Days | 199.26 Days |
5yr Average Interest Coverage Ratio
|
2.31 | 396.11 | 5.07 |
5yr Avg ROCE
|
16.75 % | 8.42 % | 8.16 % |
5yr Avg Operating Profit Margin
|
8.32 % | 10.14 % | 9.07 % |
5 yr average Debt to Equity
|
0.86 | 0.08 | 0.14 |
5yr CAGR Net Profit
|
52.4 % | -6.01 % | 77.02 % |
5yr Average Return on Assets
|
3.05 % | 6.69 % | 3.38 % |
Shareholdings
|
|||
Promoter Holding
|
48.93 % | 41.76 % | 69.23 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-2.11 % | 0.0 | 0.98 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Fredun Pharma
|
Venus Remedies
|
Kilitch Drugs(India)
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|